{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T20:16:59Z","timestamp":1771877819555,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T00:00:00Z","timestamp":1642377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00120-021-01753-9","type":"journal-article","created":{"date-parts":[[2022,1,17]],"date-time":"2022-01-17T11:02:41Z","timestamp":1642417361000},"page":"250-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["S2k-Leitlinie Diagnostik und Therapie der interstitiellen Zystitis (IC\/BPS)","S2K guideline on the diagnosis and treatment of interstitial cystitis (IC\/BPS)"],"prefix":"10.1007","volume":"61","author":[{"given":"J.","family":"Tolle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. T.","family":"Kaftan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Th.","family":"Bschleipfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,17]]},"reference":[{"key":"1753_CR1","volume-title":"S2k Leitlinie \u201eDiagnostik und Therapie der Interstitiellen Zystitis (IC\/BPS)\u201c \u2013 AWMF Registry No. 043\u2013050","author":"T Bschleipfer","year":"2018","unstructured":"Bschleipfer\u00a0T, Doggweiler\u00a0R, M\u00fcndner-Hensen\u00a0B, Schultz-Lampel\u00a0D, de Jong\u00a0J, Gonsior\u00a0A, Hensen\u00a0J, He\u00dfd\u00f6rfer\u00a0E, Kaftan\u00a0BT, Kuhn\u00a0A, Kunzendorf\u00a0U, Lampel\u00a0A, Landmesser\u00a0A, Loch\u00a0A, Moormann\u00a0O, M\u00fcller\u00a0B, Neuhaus\u00a0J, Reich\u00a0A, Roth\u00a0R, Schumacher\u00a0S, Stratmeyer\u00a0R, Vahlensieck\u00a0W, W\u00f6rdehoff\u00a0A (2018) S2k Leitlinie \u201eDiagnostik und Therapie der Interstitiellen Zystitis (IC\/BPS)\u201c \u2013 AWMF Registry No. 043\u2013050"},{"issue":"5","key":"1753_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1002\/nau.22604","volume":"33","author":"LA Birder","year":"2014","unstructured":"Birder\u00a0LA et al (2014) Urothelial mucosal signaling and the overactive bladder-ICI-RS 2013. Neurourol Urodyn 33(5):597\u2013601","journal-title":"Neurourol Urodyn"},{"issue":"4","key":"1753_CR3","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.juro.2011.05.047","volume":"186","author":"V Sanchez-Freire","year":"2011","unstructured":"Sanchez-Freire\u00a0V et al (2011) Acid-sensing channels in human bladder: expression, function and alterations during bladder pain syndrome. J\u00a0Urol 186(4):1509\u20131516","journal-title":"J Urol"},{"issue":"5","key":"1753_CR4","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.juro.2013.05.049","volume":"190","author":"Y Homma","year":"2013","unstructured":"Homma\u00a0Y et\u00a0al (2013) Increased mRNA expression of genes involved in pronociceptive inflammatory reactions in bladder tissue of interstitial cystitis. J\u00a0Urol 190(5):1925\u20131931","journal-title":"J Urol"},{"key":"1753_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/iju.12314","volume":"21","author":"Y Homma","year":"2014","unstructured":"Homma\u00a0Y (2014) Hypersensitive bladder: a solution to confused terminology and ignorance concerning interstitial cystitis. Int J Urol 21:43\u201347","journal-title":"Int J Urol"},{"issue":"7","key":"1753_CR6","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/iju.13118","volume":"23","author":"Y Homma","year":"2016","unstructured":"Homma\u00a0Y et\u00a0al (2016) Clinical guidelines for interstitial cystitis and hypersensitive bladder updated in 2015. Int J Urol 23(7):542\u2013549","journal-title":"Int J Urol"},{"issue":"6","key":"1753_CR7","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/S0022-5347(05)66918-2","volume":"164","author":"HB Goldman","year":"2000","unstructured":"Goldman\u00a0HB (2000) Interstitial cystitis\u2014the great enigma. J\u00a0Urol 164(6):1921","journal-title":"J Urol"},{"issue":"9","key":"1753_CR8","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/s00120-004-0664-9","volume":"43","author":"A Loch","year":"2004","unstructured":"Loch\u00a0A, Stein\u00a0U (2004) Interstitielle Zystitis. Urologe\u00a0A 43(9):1135\u20131146","journal-title":"Urologe A"},{"issue":"7","key":"1753_CR9","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1442-2042.2009.02326.x","volume":"16","author":"Y Homma","year":"2009","unstructured":"Homma\u00a0Y et\u00a0al (2009) Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol 16(7):597\u2013615","journal-title":"Int J Urol"},{"issue":"6","key":"1753_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/S0090-4295(01)01122-0","volume":"57","author":"JM Park","year":"2001","unstructured":"Park\u00a0JM (2001) Is interstitial cystitis an underdiagnosed problem in children? A diagnostic and therapeutic dilemma. Urology 57(6):30\u201331","journal-title":"Urology"},{"key":"1753_CR11","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ejogrb.2013.12.041","volume":"175","author":"N Davis","year":"2014","unstructured":"Davis\u00a0N, Brady\u00a0C, Creagh\u00a0T (2014) Interstitial cystitis\/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol 175:30\u201337","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"1753_CR12","doi-asserted-by":"publisher","first-page":"e92","DOI":"10.1055\/a-0610-3211","volume":"49","author":"BT Kaftan","year":"2018","unstructured":"Kaftan\u00a0BT, Wiedemann\u00a0A (2018) Hydrodistension der Harnblase zur Diagnostik und Therapie. Aktuelle Urol 49(2):e92","journal-title":"Aktuelle Urol"},{"issue":"10","key":"1753_CR13","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/j.1464-410X.2009.08675.x","volume":"104","author":"HT Liu","year":"2009","unstructured":"Liu\u00a0HT et\u00a0al (2009) Urinary nerve growth factor level is increased in patients with interstitial cystitis\/bladder pain syndrome and decreased in responders to treatment. BJU Int 104(10):1476\u20131481","journal-title":"BJU Int"},{"issue":"11","key":"1753_CR14","doi-asserted-by":"publisher","first-page":"e0143316","DOI":"10.1371\/journal.pone.0143316","volume":"10","author":"D Maeda","year":"2015","unstructured":"Maeda\u00a0D et al (2015) Hunner-type (classic) interstitial cystitis: a distinct inflammatory disorder characterized by pancystitis, with frequent expansion of clonal B\u2011cells and epithelial denudation. Plos One 10(11):e143316","journal-title":"Plos One"},{"issue":"8","key":"1753_CR15","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1002\/nau.22837","volume":"35","author":"A Niimi","year":"2015","unstructured":"Niimi\u00a0A et al (2015) Hydrodistension with or without fulguration of hunner lesions for interstitial cystitis: long-term outcomes and prognostic predictors. Neurourol Urodynam 35(8):965\u2013969","journal-title":"Neurourol Urodynam"},{"issue":"6","key":"1753_CR16","doi-asserted-by":"publisher","first-page":"473","DOI":"10.5489\/cuaj.1178","volume":"3","author":"RA Payne","year":"2009","unstructured":"Payne\u00a0RA et\u00a0al (2009) Endoscopic ablation of Hunner\u2019s lesions in interstitial cystitis patients. Can Urol Assoc\u00a0J 3(6):473\u2013477","journal-title":"Can Urol Assoc J"},{"issue":"6","key":"1753_CR17","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1016\/j.juro.2012.08.013","volume":"188","author":"JH Hillelsohn","year":"2012","unstructured":"Hillelsohn\u00a0JH et al (2012) Fulguration for Hunner ulcers: long-term clinical outcomes. J\u00a0Urol 188(6):2238\u20132241","journal-title":"J Urol"},{"issue":"1","key":"1753_CR18","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.urology.2014.09.012","volume":"85","author":"A Chennamsetty","year":"2015","unstructured":"Chennamsetty\u00a0A et\u00a0al (2015) Electrosurgical management of Hunner ulcers in a\u00a0referral center\u2019s interstitial cystitis population. Urology 85(1):74\u201378","journal-title":"Urology"},{"issue":"1","key":"1753_CR19","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.eururo.2007.09.019","volume":"53","author":"JP van de Merwe","year":"2008","unstructured":"van de Merwe\u00a0JP et\u00a0al (2008) Diagnostic criteria, classification, and nomenclature for painful bladder syndrome\/interstitial cystitis: an ESSIC proposal. Eur Urol 53(1):60\u201367","journal-title":"Eur Urol"},{"issue":"6","key":"1753_CR20","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1016\/j.juro.2015.01.036","volume":"193","author":"M Gamper","year":"2015","unstructured":"Gamper\u00a0M et\u00a0al (2015) Are mast cells still good biomarkers for bladder pain syndrome\/interstitial cystitis? J\u00a0Urol 193(6):1994\u20132000","journal-title":"J Urol"},{"issue":"8","key":"1753_CR21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1442-2042.2000.00197.x","volume":"7","author":"T Yamada","year":"2000","unstructured":"Yamada\u00a0T et\u00a0al (2000) Subtypes of bladder mast cells in interstitial cystitis. Int J Urol 7(8):292\u2013297","journal-title":"Int J Urol"},{"key":"1753_CR22","first-page":"43","volume-title":"Interstitielle Cystits\u2014The State of the Art","author":"S St\u00f6rkel","year":"2002","unstructured":"St\u00f6rkel\u00a0S (2002) Interstitielle Cystitis aus der Sicht der Pathologen. In: Interstitielle Cystits\u2014The State of the Art. Biermann, K\u00f6ln, S\u00a043\u201348"},{"issue":"5","key":"1753_CR23","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00345-011-0774-0","volume":"30","author":"J Neuhaus","year":"2012","unstructured":"Neuhaus\u00a0J et\u00a0al (2012) Individual receptor profiling as a\u00a0novel tool to support diagnosis of bladder pain syndrome\/interstitial cystitis (BPS\/IC). World J Urol 30(5):693\u2013700","journal-title":"World J Urol"},{"issue":"5","key":"1753_CR24","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/nau.22760","volume":"35","author":"HC Kuo","year":"2016","unstructured":"Kuo\u00a0HC et al (2016) Intravesical botulinum toxin\u2014A injections reduce bladder pain of interstitial cystitis\/bladder pain syndrome refractory to conventional treatment\u2014A prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn 35(5):609\u2013614","journal-title":"Neurourol Urodyn"},{"issue":"9","key":"1753_CR25","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/iju.12833","volume":"22","author":"Y Akiyama","year":"2015","unstructured":"Akiyama\u00a0Y et\u00a0al (2015) Botulinum toxin type A injection for refractory interstitial cystitis: A randomized comparative study and predictors of treatment response. Int J Urol 22(9):835\u2013841","journal-title":"Int J Urol"},{"issue":"2","key":"1753_CR26","first-page":"109","volume":"16","author":"CL Lee","year":"2013","unstructured":"Lee\u00a0CL, Kuo\u00a0HC (2013) Intravesical botulinum toxin a\u00a0injections do not benefit patients with ulcer type interstitial cystitis. Pain Phys 16(2):109\u2013116","journal-title":"Pain Phys"},{"issue":"5","key":"1753_CR27","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1016\/j.urology.2014.01.018","volume":"83","author":"R Pinto","year":"2014","unstructured":"Pinto\u00a0R et\u00a0al (2014) Ulcerative and nonulcerative forms of bladder pain syndrome\/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A. Urology 83(5):1030\u20131034","journal-title":"Urology"},{"issue":"3","key":"1753_CR28","doi-asserted-by":"publisher","first-page":"F816","DOI":"10.1152\/ajprenal.90733.2008","volume":"297","author":"S Tseng-Rogenski","year":"2009","unstructured":"Tseng-Rogenski\u00a0S, Liebert\u00a0M (2009) Interleukin\u20118 is essential for normal urothelial cell survival. Am J Physiol Renal Physiol 297(3):F816\u2013F821","journal-title":"Am J Physiol Renal Physiol"},{"issue":"2b","key":"1753_CR29","doi-asserted-by":"publisher","first-page":"E136","DOI":"10.1111\/j.1464-410X.2010.09911.x","volume":"108","author":"JH Shie","year":"2011","unstructured":"Shie\u00a0JH, Kuo\u00a0HC (2011) Higher levels of cell apoptosis and abnormal E\u2011cadherin expression in the urothelium are associated with inflammation in patients with interstitial cystitis\/painful bladder syndrome. BJU Int 108(2b):E136\u2013E141","journal-title":"BJU Int"},{"issue":"3","key":"1753_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1464-410X.2010.09843.x","volume":"107","author":"CL Parsons","year":"2011","unstructured":"Parsons\u00a0CL (2011) The role of a\u00a0leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis\/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. BJU Int 107(3):370\u2013375","journal-title":"BJU Int"},{"issue":"1","key":"1753_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000071096","volume":"71","author":"H-C Kuo","year":"2003","unstructured":"Kuo\u00a0H\u2011C (2003) Urodynamic study and potassium sensitivity test for women with frequency-urgency syndrome and interstitial cystitis. Urol Int 71(1):61\u201365","journal-title":"Urol Int"},{"issue":"7","key":"1753_CR32","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1111\/j.1464-410X.2005.05776.x","volume":"96","author":"SK Gupta","year":"2005","unstructured":"Gupta\u00a0SK, Pidcock\u00a0L, Parr\u00a0NJ (2005) The potassium sensitivity test: a\u00a0predictor of treatment response in interstitial cystitis. BJU Int 96(7):1063\u20131066","journal-title":"BJU Int"},{"issue":"4","key":"1753_CR33","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1159\/000447863","volume":"39","author":"J-S Pyo","year":"2016","unstructured":"Pyo\u00a0J\u2011S, Cho\u00a0WJ (2016) Systematic review and meta-analysis of intravesical hyaluronic acid and hyaluronic acid\/chondroitin sulfate instillation for interstitial cystitis\/painful bladder syndrome. Cell Physiol Biochem 39(4):1618\u20131625","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"1753_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1743-6109.2011.02542.x","volume":"9","author":"CL Parsons","year":"2012","unstructured":"Parsons\u00a0CL et\u00a0al (2012) Alkalinized lidocaine and heparin provide immediate relief of pain and urgency in patients with interstitial cystitis. J\u00a0Sex Med 9(1):207\u2013212","journal-title":"J Sex Med"},{"issue":"3","key":"1753_CR35","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1089\/end.1998.12.269","volume":"12","author":"CR Riedl","year":"1998","unstructured":"Riedl\u00a0CR et\u00a0al (1998) Electromotive drug administration and hydrodistention for the treatment of interstitial cystitis. J\u00a0Endourol 12(3):269\u2013272","journal-title":"J Endourol"},{"issue":"6","key":"1753_CR36","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1016\/S0022-5347(01)63174-4","volume":"159","author":"CR Riedl","year":"1998","unstructured":"Riedl\u00a0CR et\u00a0al (1998) Intravesical electromotive drug administration technique: preliminary results and side effects. J\u00a0Urol 159(6):1851\u20131856","journal-title":"J Urol"},{"issue":"2","key":"1753_CR37","first-page":"143","volume":"9","author":"PM Hanno","year":"1991","unstructured":"Hanno\u00a0PM, Wein\u00a0AJ (1991) Conservative therapy of interstitial cystitis. Semin Urol 9(2):143\u2013147","journal-title":"Semin Urol"},{"issue":"5","key":"1753_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0090-4295(98)00071-5","volume":"51","author":"K Pranikoff","year":"1998","unstructured":"Pranikoff\u00a0K, Constantino\u00a0G (1998) The use of amitriptyline in patients with urinary frequency and pain. Urology 51(5):179\u2013181","journal-title":"Urology"},{"issue":"Suppl","key":"1753_CR39","first-page":"279A","volume":"143","author":"A Kirkemo","year":"1990","unstructured":"Kirkemo\u00a0A, Miles\u00a0B, Peters\u00a0J (1990) Use of amitriptyline in interstitial cystitis. J\u00a0Urol 143(Suppl):279A","journal-title":"J Urol"},{"key":"1753_CR40","volume-title":"Pharmakologie kompakt; Allgemeine und Klinische Pharmakologie, Toxikologie","author":"E Mutschler","year":"2016","unstructured":"Mutschler\u00a0E et\u00a0al (2016) Pharmakologie kompakt; Allgemeine und Klinische Pharmakologie, Toxikologie Bd. 1. Wissenschaftliche Verlagsgesellschaft, Stuttgart"},{"issue":"3","key":"1753_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1046\/j.1464-410x.2001.02031.x","volume":"87","author":"R Thilagarajah","year":"2001","unstructured":"Thilagarajah\u00a0R, Witherow\u00a0RO, Walker\u00a0MM (2001) Oral cimetidine gives effective symptom relief in painful bladder disease: a\u00a0prospective, randomized, double-blind placebo-controlled trial. BJU Int 87(3):207\u2013212","journal-title":"BJU Int"},{"issue":"1","key":"1753_CR42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/SPV.0b013e3182044b5c","volume":"17","author":"R Bassaly","year":"2011","unstructured":"Bassaly\u00a0R, Downes\u00a0K, Hart\u00a0S (2011) Dietary consumption triggers in interstitial cystitis\/bladder pain syndrome patients. Female Pelvic Med Reconstr Surg 17(1):36\u201339","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"1","key":"1753_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.juro.2007.03.020","volume":"178","author":"B Shorter","year":"2007","unstructured":"Shorter\u00a0B et\u00a0al (2007) Effect of comestibles on symptoms of interstitial cystitis. J\u00a0Urol 178(1):145\u2013152","journal-title":"J Urol"},{"issue":"6","key":"1753_CR44","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.juro.2013.11.055","volume":"191","author":"B Shorter","year":"2014","unstructured":"Shorter\u00a0B et al (2014) Statistical validation of the shorter-moldwin food sensitivity questionnaire for patients with interstitial cystitis\/bladder pain syndrome. J\u00a0Urol 191(6):1793\u20131801","journal-title":"J Urol"},{"issue":"11","key":"1753_CR45","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1111\/j.1464-410X.2011.10860.x","volume":"109","author":"JI Friedlander","year":"2012","unstructured":"Friedlander\u00a0JI, Shorter\u00a0B, Moldwin\u00a0RM (2012) Diet and its role in interstitial cystitis\/bladder pain syndrome (IC\/BPS) and comorbid conditions. BJU Int 109(11):1584\u20131591","journal-title":"BJU Int"},{"issue":"3","key":"1753_CR46","doi-asserted-by":"publisher","first-page":"341","DOI":"10.5056\/jnm16203","volume":"23","author":"A Fabisiak","year":"2017","unstructured":"Fabisiak\u00a0A et\u00a0al (2017) Targeting histamine receptors in irritable bowel syndrome: a critical appraisal. J\u00a0Neurogastroenterol Motil 23(3):341\u2013348","journal-title":"J Neurogastroenterol Motil"},{"issue":"1","key":"1753_CR47","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1172\/JCI92390","volume":"128","author":"SY Zhou","year":"2018","unstructured":"Zhou\u00a0SY et al (2018) FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction. J\u00a0Clin Invest 128(1):267\u2013280","journal-title":"J Clin Invest"},{"issue":"5","key":"1753_CR48","first-page":"563","volume":"4","author":"RE Hurst","year":"2015","unstructured":"Hurst\u00a0RE, et\u00a0al (2015) Increased bladder permeability in interstitial cystitis\/painful bladder syndrome. Transl Androl Urol 4(5):563\u2013571","journal-title":"Transl Androl Urol"},{"issue":"1","key":"1753_CR49","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12016-011-8291-x","volume":"42","author":"A Fasano","year":"2012","unstructured":"Fasano\u00a0A (2012) Leaky gut and autoimmune diseases. Clin Rev Allergy Immunol 42(1):71\u201378","journal-title":"Clin Rev Allergy Immunol"},{"key":"1753_CR50","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/1471-2180-12-205","volume":"12","author":"H Siddiqui","year":"2012","unstructured":"Siddiqui\u00a0H et\u00a0al (2012) Alterations of microbiota in urine from women with interstitial cystitis. BMC Microbiol 12:205","journal-title":"BMC Microbiol"},{"key":"1753_CR51","doi-asserted-by":"publisher","first-page":"26083","DOI":"10.1038\/srep26083","volume":"6","author":"A Braundmeier-Fleming","year":"2016","unstructured":"Braundmeier-Fleming\u00a0A et al (2016) Stool-based biomarkers of interstitial cystitis\/bladder pain syndrome. Sci Rep 6:26083","journal-title":"Sci Rep"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-021-01753-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-021-01753-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-021-01753-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T22:17:19Z","timestamp":1666304239000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-021-01753-9"}},"subtitle":["Diskussion der aktuellen Leitlinie anhand eines Fallbeispiels","Discussion of the current guideline using a case study"],"short-title":[],"issued":{"date-parts":[[2022,1,17]]},"references-count":51,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["1753"],"URL":"https:\/\/doi.org\/10.1007\/s00120-021-01753-9","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,17]]},"assertion":[{"value":"20 December 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Th. Bschleipfer gibt Berater- und Vortragst\u00e4tigkeiten f\u00fcr Dr. R. Pfleger von 2017 bis heute, Astellas von 2017 bis 2019, Apogepha in 2018, Ferring in 2019 und Gr\u00fcnenthal von 2017 bis 2019 an. B.T. Kaftan ist Auditor der Onkozert GmbH, Mitglied der DGU, DKG, BDU, ICS, ICA und EAU und gibt Beratert\u00e4tigkeiten f\u00fcr Dr. Pfleger, Uromed und Bene Pharma an. J. Tolle ist Mitglied der DGU und GESRU.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}